Inventiva S.A Inventiva (NASDAQ: IVA) Share Half-Year Report of its Liquidity Contract with Kepler Cheuvreux Inventiva S.A. (NASDAQ: IVA) has revealed the half-year report of its liquidity contract with Kepler Cheuvreux. Inventiva has earned a reputation as a clinical-stage biopharmaceutical company focused on the
